Practice Management

Top Story

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
November 16, 2017

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

“Ninety percent doesn’t sound so good if it’s you,” Gottlieb, now 44, told HemOnc Today following a keynote presentation at the Friends of Cancer Research Annual Meeting. “So, to me, that 10% sounded pretty grim.”

In the Journals

Opioid abuse treatment medications equally effective

November 15, 2017
Buprenorphine-naloxone combination and extended-release naltrexone were both safe and effective in managing patients with opioid use disorder, yielding nearly identical…
Meeting News

AMA adopts new strategy for genetic tests, therapeutics

November 15, 2017
AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and precision medicine, a…

FDA warns against use of kratom

November 14, 2017
The FDA issued a warning today about the potentially fatal risks linked to kratom, a plant-based product from Asia that the agency said is used to treat medical…
More Headlines »
Advertisement
Advertisement